Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 USD | +1.08% | -12.15% | +70.91% |
May. 14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.91% | 34.33M | |
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+36.64% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Guggenheim Starts Xilio Therapeutics at Buy With $40 Price Target